Allowing Greater Access to Safe and Effective Contraception Act
See how your representatives voted on this bill.
DeepSyte matches this bill to the issues you care about and shows whether your reps' votes line up — not party, not press releases. Take the 2-minute values quiz to see your alignment.
Alignment with your views
Sign in and take the values quiz to see how this bill lines up with what you've said.
Summary
This bill directs the FDA to give priority review to supplemental applications for oral contraceptive drugs intended for routine use and waives associated FDA fees for such applications. For individuals 18 and older, approved drugs would be available over-the-counter; for those under 18, they would remain prescription-only. The bill also requires the Comptroller General to study federal funding of contraceptive methods over the preceding 15 years across Medicare, Medicaid, and other federal health programs.
Values analysis
Sign in and take the values quiz to get a personalized read on how this bill lines up with your positions.
How your representatives voted
Sign in to see how your representatives voted on this bill.